Horizon Discovery Ltd

Type: Company
Name: Horizon Discovery Ltd
First reported 11 hours ago - Updated 3 hours ago - 4 reports

Xenograft models of breast cancer

Horizon Discovery Group , a leading provider of products, services and technologies in the field of genome engineering, has announced the launch of its patient-derived xenograft (PDX) models of breast cancer under its Sage Labs brand. The new panel is ... [Published Scientist Live - 5 hours ago]
First reported Oct 21 2014 - Updated Oct 21 2014 - 1 reports

HORIZON DISCOVERY : Drug Discovery USA Congress

21/10/2014 | Boston, USADrug Discovery USA CongressThis congress brings together a host of senior level experts to discuss recent developments in the industry and debate the best strategies and solutions to improve drug discovery going forward.The drug ... [Published 4 Traders - Oct 21 2014]
First reported Oct 20 2014 - Updated Oct 20 2014 - 1 reports

Cambridge Index rises 4.3%

20 October 2014LatestThe Cambridge Index climbed 4.3% or 619.65 points to 14,893.9, as seven of the top ten index heavy-weights posted weekly gains. ARM Holdings rose 3.9%, despite mixed broker reviews. Investec cut its price target from 380.0p to 350.0p ... [Published NW Brown Group Limited - Oct 20 2014]
First reported Oct 17 2014 - Updated Oct 17 2014 - 1 reports

Horizon Discovery Group PLC Rating Reiterated by Beaufort Securities (HZD)

Horizon Discovery Group PLC (LON:HZD)Other equities research analysts have also recently issued reports about the stock. Analysts at Panmure Gordon reiterated a "buy" rating on shares of Horizon Discovery Group PLC in a research note on Wednesday. They ... [Published American Banking News - Oct 17 2014]
First reported Oct 16 2014 - Updated Oct 16 2014 - 1 reports

Horizon division bags collaboration agreement

Horizon Discovery Group has signed a collaboration agreement with a pharmaceutical company worth almost £300,000.The Cambridge-based company, a provider of research tools to support translational genomics and the development of personalised medicines, ... [Published Insider Media Limited - Oct 16 2014]
First reported Oct 16 2014 - Updated Oct 16 2014 - 1 reports

Beaufort Securities Breakfast Alert including KEFI Minerals, Rose Petroleum, Fox Marble,Horizon Discovery Group

China’s aggregate financing rises in September   The investments discussed here may not be suitable for you. You should read the Important Risk Warnings & Disclaimers at the foot of this newsletter.   The Markets   Market opening: Markets are likely ... [Published Proactiveinvestors United Kingdom website - Oct 16 2014]
First reported Oct 16 2014 - Updated Oct 16 2014 - 1 reports

Panmure Gordon Reaffirms Buy Rating for Horizon Discovery Group PLC (HZD)

Horizon Discovery Group PLC (LON:HZD)HZD has been the subject of a number of other recent research reports. Analysts at N+1 Singer initiated coverage on shares of Horizon Discovery Group PLC in a research note on Wednesday, October 8th. They set a "buy" ... [Published American Banking News - Oct 16 2014]
First reported Oct 08 2014 - Updated Oct 08 2014 - 3 reports

Horizon Discovery Group positioned to grab a share of US19bn market

N+1 Singer has initiated coverage of personalised medicine firm () with a ‘buy’ recommendation and a price target of 183p.The broker asserts that the only way to offer truly personalised medicine to individual patients is to compare healthy and diseased ... [Published Proactive Investors.co.uk - Oct 08 2014]
First reported Oct 06 2014 - Updated Oct 06 2014 - 8 reports

Horizon Discovery Group Signs Co-Exclusive Commercial Agreement with Haplogen Genomics

Horizon Discovery Group plc (http://www.horizondiscovery.com/) (LSE:HZD) (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced it has entered a worldwide co-exclusive ... [Published b3c Newswire - Oct 06 2014]
First reported Sep 29 2014 - Updated Sep 29 2014 - 14 reports

Horizon is world leader in gene-editing with Sage buy

The UK’s Horizon Discovery is acquiring Sage Labs of the USA in a deal which it says will create “the world’s leading gene-editing and translational genomics company”.The Cambridge-headquarted group is paying up to $48 million ($16 million in cash and ... [Published Pharma Times - Sep 29 2014]
First reported Sep 25 2014 - Updated Sep 25 2014 - 7 reports

Horizon Dis Grp plc : Additional Listing

Horizon Discovery Group plcAdditional ListingThe Company has issued and allotted 92,023 new ordinary shares pursuant to the exercise of options.Accordingly, application has been made for 92,023 new ordinary shares to be admitted to trading on AIM and ... [Published Investegate - Sep 25 2014]
First reported Sep 23 2014 - Updated Sep 23 2014 - 10 reports

Horizon Discovery Loss Widens, Expects Stronger Second Half

LONDON (Alliance News) - Horizon Discovery Group PLC Tuesday said its loss widened in the first half of the year, as it expected, but it expects a stronger second half when the full effects of its CombinatoRx acquisition will be realised.... ... [Published Wall Street Business Network - Sep 23 2014]

Quotes

Dr David Smoller, Chief Business Officer, Horizon, commented: "Patient-derived xenografts are highly translational and relevant models of human cancers, and have been invaluable tools for oncology research. However, their utility has previously been somewhat limited by incomplete characterization. SAGE Labs' new collection of PDX breast cancer models, sourced from the labs of Drs. Matt Ellis and Shunqiang Li at Washington University, is highly characterized, unlocking their full potential and making them an exciting addition to Horizon's offering."
"This latest contract with a top ten pharma in the oncology space continues to demonstrate the potential of this business and the value Horizon CombinatoRx can offer to support key drug discovery and development programs in cancer."
" () quarterly update revealed a period of significant progress towards the start of construction of its flagship project in Ethiopia next year."
"Three things got us out of bed every day," he says of Horizon’s early years. "One was to make a difference to cancer patients. The second was to show you could build great British business. And the third was to show you can build an international business from the UK, with the ambition to lead the sector and be a consolidator of American companies rather than other way round."

More Content

All (147) | News (135) | Reports (0) | Blogs (12) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Xenograft models of breast cancer [Published Scientist Live - 5 hours ago]
Horizon launches collection of Patient-Derived ... [Published Cambridge Network - 8 hours ago]
Horizon Discovery : Launches Collection of High... [Published 4 Traders - 11 hours ago]
Horizon Discovery Group Launches Collection of ... [Published Noodls - 11 hours ago]
GMP challenges holding back Big Pharma's person... [Published In-Pharmatechnologist - Oct 21 2014]
HORIZON DISCOVERY : Drug Discovery USA Congress [Published 4 Traders - Oct 21 2014]
Cambridge Index rises 4.3% [Published NW Brown Group Limited - Oct 20 2014]
Horizon Discovery Group PLC Rating Reiterated b... [Published American Banking News - Oct 17 2014]
Horizon division bags collaboration agreement [Published Insider Media Limited - Oct 16 2014]
Beaufort Securities Breakfast Alert including K... [Published Proactiveinvestors United Kingdom website - Oct 16 2014]
Panmure Gordon Reaffirms Buy Rating for Horizon... [Published American Banking News - Oct 16 2014]
Proactive news summary: Anglo Asian Mining, acc... [Published Proactive Investors.co.uk - Oct 15 2014]
Horizon Discovery Wins Drug Screening Contract [Published Contract Pharma - Oct 15 2014]
Horizon Discovery Collaborate with Top Ten Phar... [Published Technology Networks - Oct 15 2014]
Horizon wins $450k deal with top 10 Pharma busi... [Published Business Weekly UK - Oct 15 2014]
UPDATE - Horizon Discovery lands $450k deal wit... [Published Proactiveinvestors United Kingdom website - Oct 15 2014]
HORIZON DISCOVERY : Unit Wins Oncology Asset Pr... [Published 4 Traders - Oct 15 2014]
Horizon Dis Grp plc : Horizon CombinatoRx Wins ... [Published Investegate - Oct 15 2014]
Horizon Discovery lands $450k deal with top ten... [Published Proactiveinvestors United Kingdom RSS feed - Oct 15 2014]
Horizon Discovery : Signs Collaboration Agreeme... [Published 4 Traders - Oct 15 2014]
Horizon Discovery Group Signs Collaboration Agr... [Published Noodls - Oct 15 2014]
Cambridge Index falls 5.2% [Published NW Brown Group Limited - Oct 13 2014]
Meet the man who wants to build Britain's bigge... [Published Telegraph - Oct 13 2014]
MBA Entrepreneurs Profit As Schools Pump Record... [Published BusinessBecause - Oct 12 2014]
Research Analysts’ New Coverage for October, 8t... [Published American Banking News - Forex - Oct 08 2014]
Horizon Discovery Group positioned to grab a sh... [Published Proactive Investors.co.uk - Oct 08 2014]
Brokers' round-up, upgrade for Cairn but downgr... [Published MoneyAM - Oct 08 2014]
HORIZON DISCOVERY : Article: CRISPR - Cas9 - En... [Published 4 Traders - Oct 08 2014]
Broker spotlight: Ebola and airlines, ITV, Bonm... [Published Proactiveinvestors United Kingdom RSS feed - Oct 08 2014]
N+1 Singer starts buy on Horizon Discovery Group, [Published Telegraph - Oct 08 2014]
1 2 3 4 5
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Beaufort Securities Breakfast Alert including K... [Published Proactiveinvestors United Kingdom website - Oct 16 2014]
China’s aggregate financing rises in September   The investments discussed here may not be suitable for you. You should read the Important Risk Warnings & Disclaimers at the foot of this newsletter.   The Markets   Market opening: Markets are likely ...
UPDATE - Horizon Discovery lands $450k deal wit... [Published Proactiveinvestors United Kingdom website - Oct 15 2014]
---ADDS BROKER COMMENT AND SHARE PRICE--- Horizon Discovery ( LON:HZD ) CombinatoRx division has landed a US$450,000 contract with a top ten pharma company. Over the next six months it will profile the unnamed company’s lead cancer drug.  Specifically, ...
Doutissima secures seed financing led by DFJ Es... [Published PE Hub Blog - Sep 11 2014]
Doutissima , a South American health and well-being forum, has raised a seed capital round led by DFJ Esprit with participation from Breega Capital . The company also signed a strategic partnership with Telefonica -backed startup accelerator Wayra ...
Solentim Embraces CRISPR and Other Rapid Gene-E... [Published Business Wire Technology News - Sep 08 2014]
BOURNEMOUTH, England--(BUSINESS WIRE)--Solentim is pleased to announce the purchase of its Cell Metric™ CLD system for monoclonality verification by Horizon Discovery Group plc, which will use it as part of internal R&D projects. ...
Solentim Embraces CRISPR and Other Rapid Gene-E... [Published Business Wire Health News - Sep 08 2014]
BOURNEMOUTH, England--(BUSINESS WIRE)--Solentim is pleased to announce the purchase of its Cell Metric™ CLD system for monoclonality verification by Horizon Discovery Group plc, which will use it as part of internal R&D projects. ...
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.